• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Non fibrolamellar hepatocellular carcinoma on a healthy liver].

作者信息

Bouomrani Salem, Kilani Ichrak, Nouma Hanène, Slama Alaeddine, Beji Maher

机构信息

Service de Médecine Interne, Hôpital Militaire de Gabes 6000, Tunisie.

Service de Gastroentérologie, Hôpital Militaire de Gabès 6000, Tunisie.

出版信息

Pan Afr Med J. 2014 Jun 18;18:155. doi: 10.11604/pamj.2014.18.155.2762. eCollection 2014.

DOI:10.11604/pamj.2014.18.155.2762
PMID:25419293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4236843/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc8/4236843/9b65d193fba2/PAMJ-18-155-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc8/4236843/55af00b08fc0/PAMJ-18-155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc8/4236843/def2d999640a/PAMJ-18-155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc8/4236843/9b65d193fba2/PAMJ-18-155-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc8/4236843/55af00b08fc0/PAMJ-18-155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc8/4236843/def2d999640a/PAMJ-18-155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc8/4236843/9b65d193fba2/PAMJ-18-155-g003.jpg

相似文献

1
[Non fibrolamellar hepatocellular carcinoma on a healthy liver].健康肝脏上的非纤维板层型肝细胞癌
Pan Afr Med J. 2014 Jun 18;18:155. doi: 10.11604/pamj.2014.18.155.2762. eCollection 2014.
2
[Comments on case reports: discovery of a nodule in a cirrhotic liver].
Gastroenterol Clin Biol. 2000 Nov;24(11):1104-9.
3
Liver rupture after transcatheter arterial chemoembolization of a giant hepatocellular carcinoma.巨大肝细胞癌经动脉化疗栓塞术后肝破裂
J Vasc Interv Radiol. 1999 Jul-Aug;10(7):895-7. doi: 10.1016/s1051-0443(99)70134-x.
4
Fibrolamellar hepatocellular carcinoma.
Radiology. 1985 Dec;157(3):583-7. doi: 10.1148/radiology.157.3.2997835.
5
Multicystic fibrolamellar hepatocellular carcinoma. CT appearance.
Clin Imaging. 1993 Jan-Mar;17(1):67-9. doi: 10.1016/0899-7071(93)90018-i.
6
Hepatocellular carcinoma presenting as a wandering abdominal lump with atypical CEUS.
Ultraschall Med. 2013 Aug;34(4):388-90. doi: 10.1055/s-0033-1335588. Epub 2013 Aug 8.
7
Microscopic incipient hepatocellular carcinoma found incidentally in a routine liver biopsy specimen.
Hepatology. 1990 Aug;12(2):291-4. doi: 10.1002/hep.1840120216.
8
[X-ray computed tomography of hepatocellular carcinomas].肝细胞癌的X线计算机断层扫描
J Radiol. 1991 Dec;72(12):663-8.
9
Diagnosis of hepatocellular carcinoma complicating liver cirrhosis: utility of repeat ultrasound-guided biopsy after unsuccessful first sampling.肝硬化合并肝细胞癌的诊断：首次采样未成功后重复超声引导下活检的效用
Cardiovasc Intervent Radiol. 2002 Jul-Aug;25(4):295-9. doi: 10.1007/s00270-001-0123-6. Epub 2002 Mar 27.
10
[Fibrolamellar liver carcinoma, an important variant of hepatocellular carcinoma].[纤维板层型肝癌，肝细胞癌的一种重要变体]
Rofo. 1987 Dec;147(6):685-7. doi: 10.1055/s-2008-1048727.

本文引用的文献

1
Hepatocellular carcinoma in non-cirrhotic liver.非肝硬化肝脏中的肝细胞癌
Rev Esp Enferm Dig. 2012 Sep;104(9):505-6. doi: 10.4321/s1130-01082012000900016.
2
The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.arginase-1 免疫染色在鉴别肝细胞癌与转移性癌和胆管细胞癌中的诊断价值与 HepPar-1 相比。
Diagn Pathol. 2012 Oct 30;7:149. doi: 10.1186/1746-1596-7-149.
3
MRI of Focal Liver Lesions.局灶性肝病变的磁共振成像
Curr Med Imaging Rev. 2012 May;8(2):107-116. doi: 10.2174/157340512800672216.
4
Hepatocellular carcinoma in patients without cirrhosis in Italy.意大利无肝硬化患者的肝细胞癌。
Dig Liver Dis. 2013 Feb;45(2):164-9. doi: 10.1016/j.dld.2012.08.018. Epub 2012 Oct 7.
5
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma.非肝硬化 HFE 血色病伴肝细胞癌患者肿瘤组织中的乙型肝炎病毒 DNA 整合。
J Hepatol. 2013 Jan;58(1):190-3. doi: 10.1016/j.jhep.2012.09.005. Epub 2012 Sep 16.
6
Hepatocarcinogenesis in non-cirrhotic liver is associated with a reduced number of clonal hepatocellular patches in non-tumorous liver parenchyma.非肝硬化肝脏中的肝癌发生与非肿瘤性肝实质中克隆性肝细胞斑块数量减少有关。
J Pathol. 2012 Nov;228(3):333-40. doi: 10.1002/path.4060. Epub 2012 Jul 3.
7
Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.氧化 DNA 损伤与肝癌细胞永生化和 mir-92 表达相关。
BMC Cancer. 2012 May 15;12:177. doi: 10.1186/1471-2407-12-177.
8
Liver transplantation for hepatocellular carcinoma in non-cirrhotic livers regardless of the number and size of tumours?
J Hepatol. 2012 Aug;57(2):235-6. doi: 10.1016/j.jhep.2012.05.001. Epub 2012 May 11.
9
Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against.非肝硬化肝脏中肝细胞腺瘤作为肝细胞癌的危险因素：反对之声
Gut. 2012 Nov;61(11):1645-6. doi: 10.1136/gutjnl-2012-302219. Epub 2012 Apr 25.
10
Cardiac metastasis of hepatocellular carcinoma in a young non-cirrhotic patient, to the left ventricle.年轻非肝硬化患者的肝细胞癌心脏转移，累及左心室。
Ann Hepatol. 2012 May-Jun;11(3):392-4.